- Home
- / MYND Life Sciences
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
MYND Life Sciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0
2024-10-29
Market Capitalization
$956.3 K
2024-10-29
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CAD | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|
| Operating expense total | 1.0K | 3.3M | 1.9M | 1.2M |
| Depreciation and amortization | 14.0K | 86.0K | 60.0K | 21.0K |
| EBITDA | (1.0K) | (3.3M) | (1.9M) | (1.2M) |
| EBIT | (15.0K) | (3.4M) | (1.9M) | (133.0K) |
| Interest expense | 10.0K | 135.0K | 663.0K | 731.0K |
| Pre tax profit | (25.0K) | (4.5M) | (3.7M) | (1.5M) |
| Income tax expense | (168.0K) | (129.0K) | ||
| Net Income | (25.0K) | (4.4M) | (3.6M) | (1.5M) |